Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06882408

The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.

Evaluation of the Photorefraction Screener Snapsight in Comparison With Cycloplegia Table-top Autorefractor in Ametropia in Pediatric Population Between 3 and 8yo, Multicenter French Study.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
315 (estimated)
Sponsor
Essilor International · Industry
Sex
All
Age
3 Years – 8 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to evaluate the performance of a photorefraction screener in terms of sensibility, sensitivity and accuracy on children aged 3 to 8 y.o. The main objectives of the study are: * Evaluate the performances of the device in comparison with the gold standard, i.e. a tabletop refractometer. * Assess the agreement of the measures obtained with the device with those obtained with the gold standard.

Detailed description

Participants after verification of their eligibility and informed consent, participate to a single evaluation visit during which several objective refraction measurements are performed with the investigational device, a tabletop refractometer and a comparable vision screener with and without cyclopegia. Additionally far vision visual acuity, strabismus assessments and subjective refraction measurement are also performed by investigators.

Conditions

Interventions

TypeNameDescription
DEVICEPhotorefraction device under investigationObjective refraction measurement with and without cyclopegia
DEVICEComparator device, Tabletop auto-refractometerObjective refraction measurement with and without cyclopegia
DEVICEComparator device, portable photorefraction deviceObjective refraction measurement with and without cyclopegia
OTHERDistance visual acuity assessmentsDistance visual acuity is assessed with the refraction measures found by the device under investigation and the comparator device with and without cyclopegia.
OTHERSubjective refraction and far visual acuitySubjective refraction is assessed and far visual acuity is assessed with the found refraction measures
OTHERStrabismus assessmentStrabismus is assessed with the refraction measures found by the device under investigation and the comparator device with and without cyclopegia.

Timeline

Start date
2025-04-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-03-18
Last updated
2025-04-29

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06882408. Inclusion in this directory is not an endorsement.